![General Commons Logo](./assets/images/crdc-logo.svg) 
# caNanoLab DOI 
-------------------------- 
## DOI:	[10.17917/ZB8P-FB40 ](http://dx.doi.org/10.17917/ZB8P-FB40 ) 
**Protocol Name:**	NCL Method PCC-2: Measuring Zeta Potential of Nanoparticles  
**Protocol Abbreviation:**	PCC-2  
**Protocol Version:**	1.2  
-------------------------- 
### Resource Type:	Protocol 
### Publication Status:	publication_status 
#### Created Date:	2020-06-11 10:12:00 
-------------------------- 
| Property | Value | 
|----------|---------| 
| Sample ID | 115900592 | 
| Sample Name | aVb3-Integrin-targeted, melittin-loaded emulsion (NCL200) | 
| Organization | Nanotechnology Characterization Laboratory | 
| Sample ID | 115900591 | 
| Sample Name | non-targeted, melittin-loaded emulsion (NCL199) | 
| Organization | Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 115900590 | 
| Sample Name | aVb3-Integrin-targeted, non-drug-loaded emulsion (NCL198) | 
| Organization | Nanotechnology Characterization Laboratory | 
| Sample ID | 115900589 | 
| Sample Name | Non-targeted, non-drug-loaded emulsion (NCL197) | 
| Organization | Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 115900565 | 
| Sample Name | Nanocapsules (NCL284) | 
| Organization | Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 115900563 | 
| Sample Name | Nanocapsules with docetaxel-lipid conjugate (NCL285) | 
| Organization | Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 115900549 | 
| Sample Name | G2 Triazine Dendrimer with Paclitaxel (NCL123) | 
| Organization | Nanotechnology_Characterization_Laboratory | 
| Sample ID | 115900534 | 
| Sample Name | Gadolinium-containing C80 endohedral metallofullerene functionalized into hydrochalarones with glycol methyl ether (NCL124) | 
| Organization | Nanotechnology_Characterization_Laboratory | 
| Sample ID | 92471311 | 
| Sample Name | Nanoemulsion + Gd + PTX (NCL57) | 
| Organization | Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Characterization ID | 115574579|115574573|115574569|115574577|115574541|115574516|115574530|115574526|115574534|115574545|115574512|115574508 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vivo|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['RP-HPLC|Zeta Potential|Dynamic Light Scattering|Transmission electron microscopy (TEM)|toxicity|hemolysis|complement activation|platelet aggregation|cell viability|cell viability|endotoxin|sterility'] | 
| Characterization ID | 115574576|115574572|115574544|115574525|115574540|115574529|115574537|115574548|115574515|115574511 | 
| Characterization Type | physico-chemical|physico-chemical|in vivo|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['Zeta Potential|Dynamic Light Scattering|toxicity|hemolysis|complement activation|platelet aggregation|cell viability|cell viability|endotoxin|sterility'] | 
| Characterization ID | 115574580|115574575|115574571|115574578|115574543|115574524|115574539|115574528|115574536|115574547|115574514|115574510 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vivo|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['RP-HPLC|Zeta Potential|Dynamic Light Scattering|Transmission electron microscopy (TEM)|toxicity|hemolysis|complement activation|platelet aggregation|cell viability|cell viability|endotoxin|sterility'] | 
| Characterization ID | 115574574|115574570|115574542|115574523|115574538|115574527|115574535|115574546|115574513|115574509 | 
| Characterization Type | physico-chemical|physico-chemical|in vivo|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['Zeta Potential|Dynamic Light Scattering|toxicity|hemolysis|complement activation|platelet aggregation|cell viability|cell viability|endotoxin|sterility'] | 
| Characterization ID | 115574370|115574372|115574358|115574360|115574362|115574364|115574368|115574366 | 
| Characterization Type | physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['Zeta Potential|Dynamic Light Scattering||complement activation|plasma coagulation|platelet aggregation|endotoxin|microbial contamination'] | 
| Characterization ID | 115574374|115574369|115574371|115574373|115574359|115574357|115574361|115574363|115574367|115574365 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['RP-HPLC|Zeta Potential|Dynamic Light Scattering|Transmission electron microscopy (TEM)|complement activation|hemolysis|plasma coagulation|platelet aggregation|endotoxin|microbial contamination'] | 
| Characterization ID | 115574199|115574198|115574192|115574195|115574201|115574196|115574200|115574202|115574197|115574193|115574215|115574214|115574212|115574213|115574207|115574205|115574206|115574208|115574209|115574210|115574211|115574204|115574203 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vivo|in vivo|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['dn/dc value|other|UV-vis Spectroscopy|Zeta Potential|AF4-MALS|MALDI-TOF|SEC-MALS|NMR|RP-HPLC|Dynamic Light Scattering|tumor growth inhibition|systemic toxicity assessment|Caspase 3 Activity Assay|drug release|complement activation|hemolysis|platelet aggregation|MTT & LDH|MTT & LDH|MTT & LDH|MTT & LDH|endotoxin|microbial contamination'] | 
| Characterization ID | 115573981|115573979|115573985|115573986|115573989|115573991|115573992|115573993|115573990|115573977|115573976|115573978|115573974|115573975 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vivo|in vivo|in vivo|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['Concentration|Zeta Potential|RP-HPLC|AFM|Dynamic Light Scattering|MR imaging|MR imaging|acute dose toxicity study|MRI relaxivity|complement activation|hemolysis|platelet aggregation|bacterial/yeast/mold|endotoxin'] | 
| Characterization ID | 92602425|92602421|92602412|92602417|93519876|93519881|93519896|93519886|93519891|92602430|92602435|93519901|93519916|93519906|93519911 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['arsenazo|ICP-OES|Dynamic Light Scattering|Zeta Potential|Caspase 3 Activity Assay|Caspase 3 Activity Assay|complement activation|hemolysis|platelet aggregation|MTT & LDH|MTT & LDH|CFU-GM|chemotaxis|leukocyte proliferation|nitric oxide'] | 
| Nanomaterial Entity Type | emulsion | 
| Nanomaterial Entity Type | emulsion | 
| Nanomaterial Entity Type | emulsion | 
| Nanomaterial Entity Type | emulsion | 
| Nanomaterial Entity Type | emulsion | 
| Nanomaterial Entity Type | emulsion | 
| Nanomaterial Entity Type | dendrimer | 
| Nanomaterial Entity Type | fullerene | 
| Nanomaterial Entity Type | emulsion | 
| Protocol ID | 88539136 | 
| Protocol Type | physico-chemical assay | 
| Protocol Name |NCL Method PCC-2: Measuring Zeta Potential of Nanoparticles | 
| Composing Element Type | composing_element_type | 
| Composing Element Chemical Name | composing_element_chemical_name | 
| File Name | protocols/20240410_15-05-49-585_NCL_Method_PCC-2.pdf | 
| File URI | protocols/20240410_15-05-49-585_NCL_Method_PCC-2.pdf | 
| Nanomaterial Entity File Type | nanomaterial_entity_file_type | 
| Chemical Association File Type Title | chemical_association_file_type_title | 
